Compartilhar
Informação da revista
Vol. 95. Núm. 4.
Páginas 533-535 (1 julho 2020)
Compartilhar
Compartilhar
Baixar PDF
Mais opções do artigo
Visitas
5660
Vol. 95. Núm. 4.
Páginas 533-535 (1 julho 2020)
Research Letter
Open Access
Cutaneous metastases from primary solid and hematopoietic neoplasms at a referral hospital in Colombia: a cross-sectional study
Visitas
5660
María Fernanda Ordóñez-Rubianoa, Victoria Lucía Dávila-Osorioa, Paula Celeste Rubiano-Mojicab,
Autor para correspondência
paula.rubiano@urosario.edu.co

Corresponding author.
, Ángela Marcela Mariño-Álvareza
a Department of Dermatology, Central Military Hospital of Bogotá, Bogotá, Colombia
b Department of General Medicine, Universidad del Rosario, Bogotá, Colombia
Este item recebeu

Under a Creative Commons license
Informação do artigo
Texto Completo
Bibliografia
Baixar PDF
Estatísticas
Tabelas (1)
Table 1. Clinical and histopathological correlation of cutaneous metastases.
Texto Completo
Dear Editor,

Cutaneous metastases (CM) represent 2% of all skin tumors and they are present in up to 10% of all cancer patients. Their clinical and histopathological manifestations are variable and depend on the primary tumor, age, and sex.1

Currently in Colombia there are no CM studies registered, therefore this is a pioneering study in the country.

An observational, retrospective, cross-sectional study was conducted. Medical records were reviewed from patients with histopathologically confirmed CM at the Central Military Hospital in Bogotá, from January 2015 to June 2018. Patients with skin primary tumors and those without follow-up records of at least six months were excluded from the analysis. A database was built in Microsoft Excel® including clinical and histopathological features of the primary tumor and metastases. Subsequently, a descriptive statistical analysis was carried out with the software SPSS v. 20®.

A total of 26 CM cases were collected, but five patients were excluded from the analysis due to the presence of primary tumors that originated in the skin. The average age was 56 years and 52.38% (n=11) were males. The primary tumors most frequently associated were those originating in the breast (28.5%), followed by the bone marrow (23.8%).

The average time between symptoms onset and diagnosis of CM was 2.84 months, and the mean number of skin lesions was 3.76. The most frequent locations were chest 28.5% (n=6) and abdomen (19%), and regarding clinical presentation, nodules 52.3% (n=11) were the most commonly seen. CM behavior was evaluated with different immunohistochemical markers, whereupon three patients with elevated Ki-67 in the CM tissue compared to the primary tumor were identified (Table 1).

Table 1.

Clinical and histopathological correlation of cutaneous metastases.

Primary tumor  Frequency  GenderAge in years (m)  Primary histological diagnosis  Metastasis histological diagnosis  Immunohistochemistry  Skin location  Type of lesion 
               
Breast  28.5%  100%  0%  57.3  Ductal adenocarcinoma (50%)  Adeno-carcinoma  Estrogen loss: oneProgesterone gain: oneCK-20 gain: oneKi-67, two patients: 10–89% and 5–30%  Chest, scalp  Nodules, plaques 
Kidney  9.5%  0%  100%  53.5  Clear cell renal cell carcinoma (100%)  Metastatic clear cell renal cell carcinoma  No changes  Scalp, finger  Nodules, pedunculated tumor 
Lung  4.7%  100%  0%  74  Adenocarcinoma  Adenocarcinoma  No changes  Abdomen  Nodule 
Bone marrow  23.8%  25%  75%  50.4  ALL (50%), AML (50%)  Leukemia cutis, leukemid  No changes  Face, abdomen, perianal area  Nodules, ulcers, plaques 
Muscle  4.7%  0%  100%  19  Epitheloid sarcoma  Epitheloid sarcoma  No changes  Face  Ulcerated nodule 
Rectum  4.7%  0%  100%  69  Adenocarcinoma  Adenocarcinoma  No changes  Superior lip  Nodule 
Parotid  4.7%  0%  100%  73  Mucoepidermoid carcinoma  Mucoepidermoid carcinoma  Her – 2 loss  Scalp  Nodules 
Brain  4.7%  0%  100%  44  Glioblastoma  Glioblastoma  Ki-67: 20–40%  Scalp  Plaques 
Lymphatic  4.7%  100%  0%  61  Follicular lymphoma  B cell lymphoma  No changes  Abdomen  Plaque 
Unknown  9.5%  50%  50%  66.5  Does not apply  Adeno-carcinoma  –  Bilateral inguinal  Tumor, nodules 

ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia.

Relapse of the primary tumor before the appearance of CM was observed in 47.6% of the patients. The majority of patients (80.9%) received systemic chemotherapy, with a skin response only in 23.8% (n=5) of all cases. Only four had an intervention for the CM (radiotherapy: three; surgery: one). The survival time after the skin diagnosis was 10.65 months.

CM are defined as a dissemination of malignant cells from a primary malignancy toward the skin, compromising the epidermis, dermis, or hypodermis.1 It occurs in up to 10.4% of all patients with cancer and represents 2% of all skin tumors.1

Despite being an uncommon entity in daily practice, they have an important clinical significance because they usually indicate advanced disease, as in the present study.2

In the majority of cases, the most frequently primary tumor associated with CM in women is breast cancer, while in men, excluding melanoma, it is lung cancer; nevertheless, the present study did not identify any male patients with CM from lung cancer.1,3

In general, carcinomas are the most common metastasis-producing type of cancer but, as shown in this report, CM originate frequently in adenocarcinomas.4

Clinically, they present a wide variety of manifestations, such as nodules, papules, plaques, tumors, and ulcers, sometimes are associated to pain, and have a tendency to affect the scalp, trunk, and neck.2

Some morphological patterns have been defined histopathologically, and from time to time these may resemble findings of the primary malignancy, in which immunochemistry plays a fundamental role.1,5

Finally, early recognition of CM has an important effect on patient prognosis, especially in those with a primary tumor of unknown origin, where histopathology can guide the diagnosis, or in patients with a recurrent tumor, where it could alert to an active cancer.

Financial support

None declared.

Authors’ contributions

Ordóñez Rubiano María Fernanda: Statistical analysis; approval of the final version of the manuscript; conception and planning of the study; drafting and editing of the manuscript; collection, analysis, and interpretation of data; participation in study design; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied cases; critical review of the literature; critical review of the manuscript.

Dávila Osorio Victoria Lucía: Statistical analysis; approval of the final version of the manuscript; conception and planning of the study; drafting and editing of the manuscript; collection, analysis, and interpretation of data; participation in study design; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied cases; critical review of the literature; critical review of the manuscript.

Rubiano Mojica Paula Celeste: Approval of the final version of the manuscript; drafting and editing of the manuscript; critical review of the literature; critical review of the manuscript.

Mariño Álvarez Ángela Marcela: Statistical analysis; approval of the final version of the manuscript; conception and planning of the study; drafting and editing of the manuscript; collection, analysis, and interpretation of data; participation in study design; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied cases; critical review of the literature; critical review of the manuscript.

Conflicts of interest

None declared.

Acknowledgment

The authors would like to thank María Janeth Vargas Manrique, MD, Dermatopathologist at the Central Military Hospital and María Isabel González Coral, MD, Pathologist.

References
[1]
I. Alcaraz, L. Cerroni, A. Rütten, H. Kutzner, L. Requena.
Cutaneous metastases from internal malignancies: a clinicopathologic and immunohistochemical review.
Am J Dermatopathol, 34 (2012), pp. 347-393
[2]
C.Y. Wong, M.A. Helm, R.E. Kalb, T.N. Helm, N.C. Zeitouni.
The presentation, pathology, and current management strategies of cutaneous metastasis.
N Am J Med Sci, 5 (2013), pp. 499-504
[3]
J.M. Schulman, M.L. Pauli, I.M. Neuhaus, R. Sanchez Rodriguez, K. Taravati, U.S. Shin, et al.
The distribution of cutaneous metastases correlates with local immunologic milieu.
J Am Acad Dermatol, 74 (2016), pp. 470-476
[4]
S. Nibhoria, K.K. Tiwana, M. Kaur, S. Kumar.
A clinicopathological and immunohistochemical correlation in cutaneous metastases from internal malignancies: a five-year study.
J Skin Cancer, 2014 (2014), pp. 793937
[5]
E.A. Choate, A. Nobori, S. Worswick.
Cutaneous metástasis of Internal Tumors.
Dermatol Clin, 37 (2019), pp. 545-554

How to cite this article: Ordóñez-Rubiano MF, Dávila-Osorio VL, Rubiano-Mojica PC, Mariño-Álvarez AM. Cutaneous metastases from primary solid and hematopoietic neoplasms at a referral hospital in Colombia, a cross-sectional study. An Bras Dermatol. 2020;95:533–5.

Study conducted at the Central Military Hospital of Bogotá, Bogotá, Colombia.

Copyright © 2020. Sociedade Brasileira de Dermatologia
Baixar PDF
Idiomas
Anais Brasileiros de Dermatologia (Portuguese)
Opções de artigo
Ferramentas
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.